Belite Bio Inc (BLTE)
NASDAQ: BLTE
· Real-Time Price · USD
63.42
1.61 (2.60%)
At close: Aug 20, 2025, 3:59 PM
62.20
-1.92%
After-hours: Aug 20, 2025, 04:18 PM EDT
Belite Bio Inc Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.28K | -10.1K | -8.68K | -9.49K | -7.87K | -6.99K | -10.94K | -6.81K | -6.89K | -6.78K | -2.4K | -2.39K | -1.07K | -2.47K | -2.47K | -2.36K | -2.36K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.5K | n/a | n/a | n/a | 7.50 | 7.5K | 7.50 | 7.50 |
Stock-Based Compensation | n/a | 8.99K | n/a | n/a | n/a | 3.82K | n/a | n/a | n/a | 1.48K | 741.50 | n/a | n/a | -444 | 765.00 | 604.50 | 604.50 |
Other Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 301.00 | n/a | -3.5 | -3.5 |
Other Non-Cash Items | 14.28K | 1.11K | 8.68K | 9.49K | 7.87K | 3.17K | 10.94K | 6.81K | 6.89K | 5.3K | 2.4K | 2.39K | 1.07K | 613.50 | 1.71K | 9.50 | 9.50 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -480K | n/a | n/a | n/a | 301.00 | 160K | -3.5 | -3.5 |
Operating Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.85M | 741.50 | n/a | n/a | -1.99K | -1.87M | -1.74K | -1.74K |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 55.5K | n/a | n/a | n/a | -18.5K | -18.5K | -37 | -37 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -431K | n/a | n/a | n/a | 1.50 | 18.5K | 7.50 | 7.50 |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -375.5K | n/a | n/a | n/a | 1.50 | -18.5K | -29.5 | -29.5 |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.17M | n/a | n/a | n/a | -291.5 | -203.75K | -203.75K | -203.75K |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.17M | n/a | n/a | n/a | -291.5 | -203.75K | -203.75K | -203.75K |
Net Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | -2.9M | 19.6M | n/a | 37.75M | 741.50 | n/a | n/a | -2.07M | -2.07M | -2.07M | -2.07M |
Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.8M | 741.50 | n/a | n/a | -20.49K | -1.89M | -1.78K | -1.78K |